Compass Therapeutics (CMPX) Change in Acquisitions & Divestments (2022 - 2026)

Compass Therapeutics (CMPX) has 5 years of Change in Acquisitions & Divestments data on file, last reported at $83.3 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Acquisitions & Divestments rose 128.68% year-over-year to $83.3 million; the trailing twelve-month figure through Mar 2026 stood at $148.2 million (up 10.87% YoY), and the FY2025 full-year result was $101.3 million, down 24.97% from the prior year.
• Change in Acquisitions & Divestments rose to $83.3 million in Q1 2026, from $24.1 million in the prior quarter.
• In the past five years, Change in Acquisitions & Divestments ranged from a high of $83.3 million in Q1 2026 to a low of $12.8 million in Q3 2022.
• A 5-year average of $36.7 million and a median of $36.2 million in 2022 frame the typical range for Change in Acquisitions & Divestments.
• Across the five-year window, Change in Acquisitions & Divestments soared 169.86% in 2023 and sank 59.52% in 2025, its largest moves.
• Tracing CMPX's Change in Acquisitions & Divestments over 5 years: stood at $36.2 million in 2022, then soared by 42.01% to $51.4 million in 2023, then plunged by 50.91% to $25.2 million in 2024, then dropped by 4.49% to $24.1 million in 2025, then jumped by 245.79% to $83.3 million in 2026.
• Business Quant data shows CMPX's Change in Acquisitions & Divestments at $83.3 million in Q1 2026, $24.1 million in Q4 2025, and $13.9 million in Q3 2025.